Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gynecological Cancer”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Not applicableActive Not RecruitingNCT05731661
What this trial is testing

Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase

Who this might be right for
Long Term Cancer Side EffectsSupportive Care in CancerCancer Survivorship Care Plan+2 more
Centre Francois Baclesse 99
Testing effectiveness (Phase 2)Looking for participantsNCT07448922
What this trial is testing

SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors

Who this might be right for
Advanced Gynecological Malignancies
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 280
Not applicableWithdrawnNCT03115528
What this trial is testing

Difference in the Estimation of Prognosis

Who this might be right for
Malignant Neoplasms of Independent (Primary) Multiple Sites
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05032040
What this trial is testing

XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Who this might be right for
Ovarian CancerClear Cell CarcinomaEndometrial Cancer+2 more
Xencor, Inc. 170
Large-scale testing (Phase 3)Study completedNCT02855944
What this trial is testing

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 349
Not applicableEnded earlyNCT06191900
What this trial is testing

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)

Who this might be right for
AdultGynecological Tumors
Grit Biotechnology 4
Early research (Phase 1)Study completedNCT02978755
What this trial is testing

First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers

Who this might be right for
Neoplasm, Gynecologic
GamaMabs Pharma 78
Testing effectiveness (Phase 2)Looking for participantsNCT06654440
What this trial is testing

A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy

Who this might be right for
Advanced Gynecological Malignancy
Shanghai Hengrui Pharmaceutical Co., Ltd. 100
Large-scale testing (Phase 3)Study completedNCT00850772
What this trial is testing

Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Queensland Centre for Gynaecological Cancer 109
Testing effectiveness (Phase 2)UnknownNCT03827837
What this trial is testing

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaCervical Cancer+2 more
Jiangsu HengRui Medicine Co., Ltd. 265
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Early research (Phase 1)Looking for participantsNCT05238922
What this trial is testing

Study of INCB123667 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 604
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07311538
What this trial is testing

Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies

Who this might be right for
Advanced Gynecological Malignancies
BioRay Pharmaceutical Co., Ltd. 56
Early research (Phase 1)Looking for participantsNCT06977126
What this trial is testing

Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers

Who this might be right for
Gynecological Cancers
University Health Network, Toronto 24
Not applicableStudy completedNCT02842047
What this trial is testing

The Mediating Effects of Decentering on Self-Management of Stress and End of Life Planning

Who this might be right for
Stage IV Gastrointestinal CancerAdvanced Gynecological Cancer
Case Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06906341
What this trial is testing

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms+1 more
Corcept Therapeutics 270
Testing effectiveness (Phase 2)Looking for participantsNCT06798207
What this trial is testing

A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced

Who this might be right for
Gynecological Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 170
Early research (Phase 1)Study completedNCT00770536
What this trial is testing

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Who this might be right for
CancerCarcinomaFallopian Tube Cancer+6 more
Amgen 103
Not applicableStudy completedNCT02340715
What this trial is testing

Advanced MRI Sequences for Radiation Therapy Treatment Planning

Who this might be right for
Cancer
Medical College of Wisconsin 158
Early research (Phase 1)Active Not RecruitingNCT05462717
What this trial is testing

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more
Revolution Medicines, Inc. 222
Load More Results